600613.SS SHH
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
1W: -13.2%
1M: -26.6%
3M: +74.3%
YTD: +25.8%
1Y: +17.5%
3Y: +27.2%
5Y: +67.1%
¥8.19 ($1.22)
+0.08 (+0.99%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$208M
-3.6% ▼
5Y CAGR: +10.1%
Capital Expenditures
$36M
-48.5% ▼
5Y CAGR: -13.9%
Free Cash Flow
$171M
-10.3% ▼
5Y CAGR: +27.3%
Dividends Paid
$64M
+3.2% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$65M
+9.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$353M | $68M | $48M | $57M | $66M |
| Depreciation & Amort. | $53M | $66M | $96M | $93M | $91M |
| Stock-Based Comp. | $22M | -$5M | $2M | $0 | $0 |
| Change in Working Capital | $47M | $64M | $135M | $26M | -$774K |
| Other Non-Cash Items | $352M | -$14M | $40M | $40M | $51M |
| Operating Cash Flow | $99M | $184M | $319M | $216M | $208M |
| — Investing Activities — | |||||
| Capital Expenditures | -$96M | -$86M | -$27M | -$25M | -$36M |
| Acquisitions (Net) | $76K | $122K | $167K | $14M | $0 |
| Investment Purchases | -$76K | -$3M | -$167K | -$20M | -$15M |
| Investment Sales | $2M | $3M | $2M | $463K | $16M |
| Other Investing | $76K | -$37K | $167K | -$463K | $393K |
| Investing Cash Flow | -$94M | -$86M | -$24M | -$30M | -$35M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$114M | -$32M | -$49M | -$59M | -$28M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$6M | -$4M | -$53M | -$66M | -$64M |
| Other Financing | -$0 | -$51M | -$31M | -$610K | -$16M |
| Financing Cash Flow | -$120M | -$86M | -$134M | -$126M | -$108M |
| Net Change in Cash | -$115M | $12M | $161M | $60M | $65M |
| Cash End of Period | $481M | $494M | $655M | $714M | $779M |
| Free Cash Flow | $3M | $98M | $293M | $191M | $171M |